This inventor holds 1 USPTO granted patent. Top assignee: Astellas Pharma Gmbh. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: Dal Oyama: Innovator in Pharmaceutical Composition
Introduction
Dal Oyama is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions for oral administration. His innovative work focuses on improving the solubility and absorbability of drugs, which is crucial for effective treatment.
Latest Patents
Dal Oyama holds a patent for a pharmaceutical composition for oral administration. The patent, which is characterized by its unique compound, 1-{5-[(5-{[(2R)-2-ethylpyrrolidin-1-yl]methyl}-4-[4-methoxy-3-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl)carbamoyl]pyrazin-2-yl}pyperidine-4-carboxylic acid, aims to enhance the solubility and absorbability of the drug. This composition also includes a cellulose derivative, making it a valuable advancement in pharmaceutical formulations.
Career Highlights
Dal Oyama is currently associated with Astellas Pharma GmbH, where he continues to innovate in the pharmaceutical sector. His work has been instrumental in developing new solutions that address critical challenges in drug delivery and effectiveness.
Collaborations
Dal Oyama has collaborated with esteemed colleagues, including Ryo Kojima and Koji Nishimura. Their combined expertise has contributed to the successful development of innovative pharmaceutical solutions.
Conclusion
Dal Oyama's contributions to pharmaceutical compositions demonstrate his commitment to advancing medical science. His innovative patent reflects a significant step forward in improving drug solubility and absorbability, ultimately benefiting patient care.